Tag Archives: Myriad Genetics

Myriad Decision: Praise and Perils for Biotechnology Patent Policy

The Supreme Court decision blocking patents on naturally-occurring genes has generated predictions of doom for biotech innovation, along with expectations of more healthy competition in discovering new treatments and diagnostics. Although some commentators regarded the decision, Association for Molecular Pathology v. Myriad Genetics, as a “major reversal” in longstanding patent policy, many leaders of the […]
Posted in Biotech, Gene therapy, IP, Legal, Technology | Also tagged , , , | 2 Comments

Judge Spikes Myriad Genetic’s Control of Genes

Image via Wikipedia Score one for nature. A US district court judge on Monday declared that pharma companies can’t patent individual genes because they are they are not, in fact, creating them. Last spring, Myriad Genetics was taken to task by the ACLU for monopolizing a patent it had discovered for breast cancer. The civil […]
Posted in Biotech, News | Also tagged , , , , , , | 1 Comment
  • Categories

  • Meta